ROCKVILLE, Md. — Novavax Inc. announced Jan. 12 that it has completed a pre-clinical safety and efficacy study of its RSV vaccine candidate in cotton rats.
ROCKVILLE, Md. — Novavax Inc. announced Jan. 12 that it has completed a pre-clinical safety and efficacy study of its RSV vaccine candidate in cotton rats.